MindMaze Therapeutics
V6M.F
#11193
Rank
NZ$3.65 M
Marketcap
NZ$0.28
Share price
-1.39%
Change (1 day)
N/A
Change (1 year)

EPS for MindMaze Therapeutics (V6M.F)

EPS in 2024: NZ-$2.76

According to MindMaze Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$2.76. In 2024 the company made an earnings per share (EPS) of NZ-$2.76 an increase over its 2023 EPS that were of NZ-$18.16.

EPS history for MindMaze Therapeutics from 2007 to 2024

Annual EPS

Year EPS Change
2024NZ-$2.76-84.79%
2023NZ-$18.1691.03%
2022NZ-$9.5118.81%
2021NZ-$8.00221.62%
2020NZ-$2.49-17.59%
2019NZ-$3.021809.94%
2018NZ-$0.16-78.95%
2017NZ-$0.75-91.95%
2016NZ-$9.339029.37%
2015NZ-$0.10-99.45%
2014NZ-$18.68-68.12%
2013NZ-$58.58292.43%
2012NZ-$14.93-97.77%
2011NZ-$669.16192.88%
2010NZ-$228.481332.73%
2009NZ-$15.95-84.42%
2008NZ-$102.34956.49%
2007NZ-$9.69